| Phase 11 trial |
|
Phase 1
|
NCT07565597 |
May 2026 → Feb 2027 expected |
— |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
Active not recruiting
|
No outcome recorded
|
| Phase 1/27 trials |
|
Phase 1/2
|
NCT07476872 |
Mar 2026 → Nov 2027 expected |
chronic graft versus host disease |
Institute of Hematology & Blood Diseases Hospital, China |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT07285889 |
Dec 2025 → Dec 2027 expected |
acute graft versus host disease |
First Affiliated Hospital of Zhejiang University |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT07080216 |
Sep 2025 → Aug 2027 expected |
cervical cancer |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT07142837 |
Sep 2025 → Oct 2027 expected |
neoplasm |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT07012304 |
Jun 2025 → Feb 2027 expected |
chronic graft versus host disease |
Yujun DONG |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT06903377 |
May 2025 → Apr 2027 expected |
non-small cell lung carcinoma |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT06883526 |
May 2025 → Apr 2027 expected |
lymphoma |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
Recruiting
|
No outcome recorded
|
| Phase 24 trials |
|
Phase 2
|
NCT07471503 |
Mar 2026 → Apr 2029 expected |
myelofibrosis |
Institute of Hematology & Blood Diseases Hospital, China |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07185633 |
Jan 2026 → Oct 2027 expected |
acute graft versus host disease |
Bin Gu |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07197112 |
Oct 2025 → Feb 2027 expected |
acute graft versus host disease |
Ruijin Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07157306 |
Sep 2025 → Jan 2027 expected |
hepatocellular carcinoma |
Tianjin Medical University Cancer Institute and Hospital |
Not yet recruiting
|
No outcome recorded
|
| Phase not applicable3 trials |
| — |
NCT07454226 |
May 2026 → Mar 2028 expected |
acute lymphoblastic leukemia, phosphohydroxylysinuria |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
| — |
NCT07445893 |
Apr → Dec 2026 expected |
acquired polycythemia vera |
Duan Minghui |
Recruiting
|
No outcome recorded
|
| — |
NCT07440654 |
Mar 2026 → Sep 2029 expected |
acute graft versus host disease |
Nanfang Hospital, Southern Medical University |
Not yet recruiting
|
No outcome recorded
|